1. Home
  2. SKLZ vs NKTX Comparison

SKLZ vs NKTX Comparison

Compare SKLZ & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SKLZ
  • NKTX
  • Stock Information
  • Founded
  • SKLZ 2012
  • NKTX 2015
  • Country
  • SKLZ United States
  • NKTX United States
  • Employees
  • SKLZ N/A
  • NKTX N/A
  • Industry
  • SKLZ EDP Services
  • NKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SKLZ Technology
  • NKTX Health Care
  • Exchange
  • SKLZ Nasdaq
  • NKTX Nasdaq
  • Market Cap
  • SKLZ 136.4M
  • NKTX 123.5M
  • IPO Year
  • SKLZ N/A
  • NKTX 2020
  • Fundamental
  • Price
  • SKLZ $7.14
  • NKTX $1.97
  • Analyst Decision
  • SKLZ Buy
  • NKTX Strong Buy
  • Analyst Count
  • SKLZ 1
  • NKTX 5
  • Target Price
  • SKLZ $14.00
  • NKTX $13.50
  • AVG Volume (30 Days)
  • SKLZ 71.3K
  • NKTX 539.6K
  • Earning Date
  • SKLZ 11-06-2025
  • NKTX 11-06-2025
  • Dividend Yield
  • SKLZ N/A
  • NKTX N/A
  • EPS Growth
  • SKLZ N/A
  • NKTX N/A
  • EPS
  • SKLZ N/A
  • NKTX N/A
  • Revenue
  • SKLZ $93,320,000.00
  • NKTX N/A
  • Revenue This Year
  • SKLZ $17.44
  • NKTX N/A
  • Revenue Next Year
  • SKLZ $12.03
  • NKTX N/A
  • P/E Ratio
  • SKLZ N/A
  • NKTX N/A
  • Revenue Growth
  • SKLZ N/A
  • NKTX N/A
  • 52 Week Low
  • SKLZ $3.54
  • NKTX $1.31
  • 52 Week High
  • SKLZ $9.11
  • NKTX $6.49
  • Technical
  • Relative Strength Index (RSI)
  • SKLZ 37.95
  • NKTX 41.11
  • Support Level
  • SKLZ $7.21
  • NKTX $2.00
  • Resistance Level
  • SKLZ $7.54
  • NKTX $2.08
  • Average True Range (ATR)
  • SKLZ 0.29
  • NKTX 0.11
  • MACD
  • SKLZ -0.19
  • NKTX -0.03
  • Stochastic Oscillator
  • SKLZ 3.67
  • NKTX 2.35

About SKLZ Skillz Inc.

Skillz Inc is a mobile game development company. It is engaged in re-inventing competitive mobile gaming and thereby expanding the mobile gaming market. Some of the games available on its platform are Dominoes Gold, Blackout Bingo, 21 Blitz, and Solitaire Cube among others. The company's reportable business segments are; the Skillz segment and the Aarki segment. The majority of its revenue is generated from the Skillz segment which is an eSports gaming platform, enabling game developers to monetize their content through multi-player competition. Geographically, the company derives its key revenue from the United States and the rest from Israel, China, Malta, and other countries.

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

Share on Social Networks: